Manning & Napier Group’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-20,860
Closed -$728K 299
2022
Q1
$728K Sell
20,860
-10,186
-33% -$348K 0.01% 262
2021
Q4
$945K Sell
31,046
-7,769
-20% -$253K 0.01% 266
2021
Q3
$1.27M Sell
38,815
-29,297
-43% -$937K 0.01% 264
2021
Q2
$2.06M Buy
+68,112
New +$2.24M 0.02% 265

Other funds holding OGN

Manning & Napier Group's OGN Position: Q2 2022 in Review

Manning & Napier Group sold out of Organon & Co (OGN) in Q2 2022, closing a stake of 20,860 shares — an estimated $728K sold.

Manning & Napier Group first reported a position in OGN in Q2 2021 and held it in 4 quarters. The position peaked at $2.06M in Q2 2021. 853 funds tracked by Wall St. Rank hold OGN as of Q2 2022.

  • Manning & Napier Group reported no remaining Organon & Co position as of Q2 2022 after selling out during the quarter.
  • Manning & Napier Group sold 20,860 Organon & Co shares in Q2 2022, an estimated $728K.
  • Manning & Napier Group first reported a position in Organon & Co in Q2 2021 and held it in 4 quarters.
  • Manning & Napier Group's Organon & Co position peaked at $2.06M in Q2 2021.
  • 853 funds tracked by Wall St. Rank held Organon & Co as of Q2 2022.

Based on Manning & Napier Group's 13F filing for Q2 2022, filed 12 Jul 2022.